Showing results (1-10 of 208) with videos related to
Sort By:
Pageof 21
Expert Opinion on Investigational Drugs|November 24, 2023
Gene expression inhibitors for the treatment of liver fibrosis: drugs under preclinical and early clinical investigationMatthias Ocker, Daniel NeureiterExpert Opinion on Therapeutic Targets|January 12, 2012
Advances in targeting the Hedgehog signaling pathway in cancer therapyTobias Kiesslich, Daniel NeureiterInternational Journal of Molecular Medicine|February 9, 2006
Gastrointestinal cancer - only a deregulation of stem cell differentiation? (Review)Daniel Neureiter, Christoph Herold, Matthias OckerExpert Review of Anticancer Therapy|November 25, 2025
Targeted therapy for biliary tract cancer: facts and fictions as well as demands and challengesDaniel Neureiter, Peter Ellinghaus, Matthias OckerMolecular and Clinical Oncology|March 21, 2014
Epigenetic control of epithelial-mesenchymal-transition in human cancerTobias Kiesslich, Martin Pichler, Daniel NeureiterHistology and Histopathology|February 19, 2009
Biomarkers for novel targeted therapies of hepatocellular carcinomaKinya Okamoto, Daniel Neureiter, Matthias OckerMedical Sciences (Basel, Switzerland)|March 27, 2026
Translating Fibrosis to Malignancy: Biomarkers and Therapeutic Opportunities in Liver Fibrosis and Hepatocellular CarcinomaDaniel Neureiter, Tobias Kiesslich, Matthias OckerCell Communication and Signaling : CCS|January 12, 2017
T cell exhaustion: from pathophysiological basics to tumor immunotherapyKemal Catakovic, Eckhard Klieser, Daniel Neureiter, et al.World Journal of Gastroenterology|July 24, 2019
Hepatocellular carcinoma: Therapeutic advances in signaling, epigenetic and immune targetsDaniel Neureiter, Sebastian Stintzing, Tobias Kiesslich, et al.Pageof 21